Cell-El Ltd. announces: We are expanding our study!!
Cell El Ltd. has been studying the effects of stem cell treatment (SCT) on biomarkers in children with ASD ages 2-12 since 2021. As our research progresses and treatment of older children with stem cells expands in the field, we too are adding older children with ASD to our study! The new cohort will be comprised of teens from age 12-18 diagnosed with ASD and scheduled to undergo stem cell treatment. As with our younger group (for which we are also still recruiting participants) we are looking for individuals who:
- Have been diagnosed with ASD using DSM
- Are male or female
- Was not treated with systemic steroids or immune suppressants less than 4 weeks
- Do not have a history of recent serious illness in the last 6 months
- Do not have serious intractable seizures or a hematologic condition
- No new planned immune-modulating treatment (other than SCT) for at least 6 months before or after planned stem cell transplantation date.
Help Us Help You
Better diagnostics for ASD based on laboratory-measured objective biomarkers can possibly enable researchers and clinicians to provide more precise and personalized treatment. You too can make a difference in the lives of children with ASD and their families by joining the Cell-El study. Cell-El is recruiting for two of our study cohorts. We are recruiting mothers, and their infants aged 10-19 months who have not been diagnosed with ASD but who have a sibling diagnosed with ASD. Cell-El is also recruiting children diagnosed with ASD between the ages of 2-18 years old whose parents are planning to take them privately to a clinic offering Stem Cell treatment for ASD.
Please contact Leah at [email protected] or fill out the form to find out about eligibility to participate in our diagnostic study and please help spread the word about the Cell-El study. Sharing our study will enable our important biomarker diagnostic tool to be integrated into autism treatment as quickly as possible.